Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 28;23(1):26.
doi: 10.1186/s12894-023-01194-w.

RNA-seq reveals novel mechanistic targets of Livin in bladder cancer

Affiliations

RNA-seq reveals novel mechanistic targets of Livin in bladder cancer

Xianwen Li et al. BMC Urol. .

Abstract

Background: Bladder cancer is a very common malignancy with a high recurrence rate. The survival of patients with muscle-invasive bladder cancer is poor, and new therapies are needed. Livin has been reported to be upregulated in bladder cancer and influence the proliferation of cancer cells.

Materials and methods: The Livin gene in human bladder cancer cell line T24 was knocked out, and the differentially expressed genes were identified by RNA-seq and qPCR.

Results: Livin knockdown affects gene expression and has strong negative effects on some cancer-promoting pathways. Furthermore, combined with bladder cancer clinical sample data downloaded from TCGA and GEO, 2 co-up-regulated genes and 58 co-down-regulated genes were identified and validated, which were associated with cancer proliferation and invasion.

Conclusion: All these results suggest that Livin plays an important role in bladder cancer and could be a potential anticancer target in clinical therapy.

Keywords: Bladder cancer; Livin; RNA-seq; T24 cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Effect of Livin knockdown in T24 cells. A The knockdown efficiency of Livin was detected in T24 cells. B Migration and invasion analysis 72 h after Livin knockdown, crystalline violet staining was performed on migrated and invading cells. C Efficiency of cell migration and invasion after 72 h of Livin knockdown. D Western blotting assays were performed to detect protein levels of E-cadherin and MMP-9 in NC group and si-Livin group, normalized by GAPDH. *P < 0.05, **P < 0.01. versus NC group
Fig. 2
Fig. 2
Effect of Livin knockdown in T24 cells on cell proliferation. A Cell apoptosis was detected by flow cytometry in NC group and si-Livin group. B Western blotting assays were performed to detect protein levels of VEGFA, EGFR, and HIF-1α in NC group and si-Livin group, normalized by GAPDH. C The protein levels of Bcl-2 in NC group and si-Livin group, normalized by GAPDH. *P < 0.05, **P < 0.01. versus NC group
Fig. 3
Fig. 3
RNA-Seq revealed differences in gene expression between T24 normal cells and Livin knockdown cells. A The heatmap of correlation coefficients within and between sample groups. B Volcano diagram displayed genes upregulated and downregulated in two groups. C Heatmaps depicting differentially expressed genes in two groups
Fig. 4
Fig. 4
Functional analyses of the differentially expressed genes between T24 normal cells and Livin knockdown cells. A GO enrichment analysis for expression of upregulated genes. BP: biological process, CC: Cellular component, MF: molecular function. B GO enrichment analysis for expression of downregulated genes. C Bubble diagram of KEGG enrichment analysis results of differential genes
Fig. 5
Fig. 5
GSEA functional enrichment analysis. A GO enrichment analysis. B KEGG enrichment analysis
Fig. 6
Fig. 6
Identification of co-differentially expressed genes from T24 cell data combined with TCGA and GEO clinical data. A Venn diagrams of the three datasets of upregulated genes. B Venn diagrams of the three datasets of downregulated genes. C RT-qPCR validation of common genes on T24 cells. *P < 0.05, **P < 0.01, ***P < 0.001. versus NC group

Similar articles

References

    1. van Kessel KE, Zuiverloon TC, Alberts AR, et al. Targeted therapies in bladder cancer: an overview of in vivo research. Nat Rev Urol. 2015;12(12):681–694. doi: 10.1038/nrurol.2015.231. - DOI - PubMed
    1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi: 10.1002/ijc.25516. - DOI - PubMed
    1. Garg M. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer Metastasis Rev. 2015;34(4):691–701. doi: 10.1007/s10555-015-9589-6. - DOI - PubMed
    1. Grayson M. Bladder cancer. Nature. 2017;551(7679):S33. doi: 10.1038/551S33a. - DOI - PubMed
    1. DeVita VT, Jr, Chu E. A history of cancer chemotherapy. Can Res. 2008;68(21):8643–8653. doi: 10.1158/0008-5472.CAN-07-6611. - DOI - PubMed

Substances